Foley Awarded 2013 M&A Advisor Deal of the Year in Healthcare/Life Sciences Category

20 December 2013 Media Contact: Jill Chanen News
Foley is pleased to announce that the firm’s work with OxOnc Development LP, was awarded “Deal of the Year in the Healthcare/Life Sciences (between $10 million to $50 million)” category at the 12th annual M&A Advisor awards gala on December 17, 2013. Foley attorneys, along with investment bankers MTS Health Partners, assisted in the formation and financing of OxOnc Development LP and its simultaneous entry into a significant development relationship with Pfizer, Inc. for the clinical development in the Peoples’ Republic of China, Japan, Taiwan and South Korea of Pfizer’s product, Xalkori, for the treatment of certain varieties of lung cancer. The Foley team consisted of Selig Sacks, Rick Kaufman, Jamshed Patel, Michael Dana and Melisande Brodeur-Frohman.

The M&A Advisor Awards recognize the leading dealmakers, firms and transactions.

Related Services


CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments
20 November 2019
Health Care Law Today
The Purpose of a Corporation
November 2019
Legal News: Business Law
Should This Be a "Mobility" Industry Blog?
19 November 2019
Dashboard Insights
Data Processing Patent Eligibility: Federal Circuit Finds Claims Eligible in KPN v. Gemalto
19 November 2019
IP Litigation Current
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
HFMA MA-RI Annual Compliance Update
12 December 2019
Boston, MA